The first Esperion Therapeutics trade was made in Q3 2013. Since then Paul Tudor Jones II bought shares fourteen more times and sold shares on eleven occasions. The investor sold all their shares in Q2 2024 and doesn't own any shares in Esperion Therapeutics anymore.